SCHEMBL17120259

SCHEMBL17120259

CC1(C)OB(c2ccc3ccc4c(-c5ccccn5)ccc5ccc2c3c54)OC1(C)C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 1/20 0.33
▸ LPL P06858 2/20 0.32
▸ LIPG Q9Y5X9 2/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ KDM4E B2RXH2 5/20 0.32
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ CCR1 P32246 2/20 0.32
▸ CCR5 P51681 2/20 0.32
▸ CCR8 P51685 2/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ TP53 P04637 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ HTT P42858 2/20 0.32
▸ ALPL P05186 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ ALPI P09923 1/20 0.32
▸ ALPG P10696 1/20 0.32
▸ ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9887332 0.87 BRD4 (0.39) PRKCILPLLIPGBRD4KDM4E
SCHEMBL17120267 0.84 LIPG (0.46) PRKCILPLLIPGKDM4ESMN1; SMN2
SCHEMBL14961217 0.80 LPL (0.44) LPLLIPGPRMT5WDR77
SCHEMBL15077962 0.79 KDM4E (0.50) PRKCIBRD4KDM4ESMN1; SMN2TDP1
SCHEMBL2816050 0.79 LPL (0.38) LPLLIPGTDP1L3MBTL1MAPK1
SCHEMBL17940739 0.78 CYP1A2 (0.37) LPLLIPGKDM4ESMN1; SMN2TDP1
SCHEMBL14298053 0.77 CCR1 (0.37) LPLLIPGKDM4ESMN1; SMN2TDP1
SCHEMBL17120269 0.77 LIPG (0.46) LPLLIPGKDM4ESMN1; SMN2LMNA
SCHEMBL20149142 0.77 KDM4E (0.41) LPLLIPGBRD4KDM4ESMN1; SMN2
SCHEMBL31520280 0.77 KDM4E (0.41) LPLLIPGBRD4KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9831443-B2 Condensed cyclic compound and organic light-emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-28 — — US disclosed
US-9831443-B2 Condensed cyclic compound and organic light-emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-28 — — US disclosed
US-20150270498-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-09-24 — — US disclosed
US-20150270498-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150270498-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME CRY1, CRY2, MCM4 PRKCI 4472/4885LPL 2063/4885LIPG 2118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback